Výsledky vyhledávání - "Mohammad Imtiaz Hassan"

Evaluation of the effectiveness and tolerability of gliclazide modified release 60 mg in patients with type 2 diabetes observing fasting during Ramadan in Pakistan: An analysis from the global DIA-RAMADAN study

Autor: Javed Akram, Yakoob Ahmedani, Azizul Hasan Aamir, Mohammad Imtiaz Hassan, Syed Abbas Raza

Publikováno v: Diabetes Research and Clinical Practice. 181:109086

Aim To assess safety and effectiveness of gliclazide MR 60 mg in people with controlled or suboptimal controlled T2DM treated with breakable gliclazide MR 60 mg formulation. Method This study data has been extracted from an international, observation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::875c8eaa18c70b604ceccdd6fa43711c
https://doi.org/10.1016/j.diabres.2021.109086

Zobrazit plný text záznamu

Switch from biphasic human insulin 30 to biphasic insulin aspart 30 in Pakistani subjects

Autor: Mohammad Imtiaz, Hassan, Azizul Hasan, Aamir, Zahid, Miyan, Laiq Ahmed, Siddiqui, Shahid, Mahmood, Ejaz Ahmed, Vohra

Publikováno v: JPMA. The Journal of the Pakistan Medical Association. 63(10)

To determine the safety and effectiveness of biphasic insulin aspart 30 (BIAsp 30) in type 2 diabetes subjects switched from biphasic human insulin 30 (BHI 30) in the Pakistani subgroup of the multinational, prospective, non-interventional A1chieve s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5b8c828002e3c79a038185f7a03aefd8
https://pubmed.ncbi.nlm.nih.gov/24392563

Zobrazit plný text záznamu

Safety and effectiveness of biphasic insulin aspart 30 (Biasp 30) in people with type 2 diabetes mellitus in the pakistani population: results from the A1chieve study

Autor: Mohammad Imtiaz, Hassan, Azizul Hasan, Aamir, Zahid, Miyan, Laiq Ahmed, Siddiqui, Muhammad Saleem, Qureshi, Muhammad Zaman, Shaikh

Publikováno v: JPMA. The Journal of the Pakistan Medical Association. 62(9)

To explore the safety and effectiveness of treatment with the insulin analogue, biphasic insulin aspart 30 (BIAsp 30), in people with type 2 diabetes mellitus (T2DM) in a subgroup of a Pakistani population from the A1chieve study.A1chieve was a 24-we

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::22182a434ebf9f7cfa4efab3ab21cbe1
https://pubmed.ncbi.nlm.nih.gov/23139978

Zobrazit plný text záznamu